Gain Therapeutics, Inc. (GANX) Reports In-Line Q3 EPS

Gain Therapeutics, Inc. (NASDAQ: GANX) reported Q3 EPS of ($0.15), in-line with the analyst estimate of ($0.15).

For earnings history and earnings-related data on Gain Therapeutics, Inc. (GANX) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Uber, Lyft trade lower on report of August launch of Tesla's CyberCab
• Eternity Founders Mohamad Al-Shami and Omar Abu Ghoush Announce US$1 Million Valuation